FDA

The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.

First drug approved for the management of acute onset of canine pancreatitis

This topical drug for humans is a deadly threat to pets

Both fluralaner topical solution (Bravecto) and fluralaner and moxidectin topical solution (Bravecto Plus) are now indicated for the treatment and control of Asian longhorned tick infestations in cats.

The product from Boehringer Ingelheim promotes the development of antibodies against rotavirus, coronavirus, and E. coli F5 (K99) adhesin

Registration is now open to attend the FDA event